Montelukast Sodium
Product Images NDC 55111-763

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 55111-763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Montelukast Sodium Oral Granules are a medication for Pediatric Patients. The medication is available in a Unit dose carton of 30 packets, where each packet contains 4 mg of the oral granules. The medication is to be taken by patients from 6 months to 5 years of age.*

FDA Label Image

Figure1 (Figure1)

The text appears to be a graph showing the change in height in centimeters over a certain number of weeks on treatment. The graph compares the results of Montelukast Sodium (at a dosage of 5mg) to Becometnasone (at a dosage of 36mg) and a placebo group.*

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Packetlabel (Packetlabel)

Montelukast Sodium is an Oral Granule medication for use in pediatric patients from 6 months to 5 years of age. It contains 4.2mg of Montelukast Sodium USP equivalent to 4mg Montelukast, and its manufacturing company is Dr. Reddy's Laboratories Limited, located in India. The medication also includes additional ingredients such as hypromellose, and sodium stearate.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.